The Clorox Company (NYSE:CLX – Free Report) – Equities research analysts at DA Davidson issued their FY2025 earnings estimates for Clorox in a report issued on Wednesday, February 5th. DA Davidson analyst L. Weiser expects that the company will post earnings per share of $6.65 for the year. DA Davidson currently has a “Neutral” rating and a $169.00 target price on the stock. The consensus estimate for Clorox’s current full-year earnings is $6.86 per share. DA Davidson also issued estimates for Clorox’s FY2026 earnings at $6.32 EPS.
Other analysts have also issued reports about the company. Wells Fargo & Company lifted their price objective on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. JPMorgan Chase & Co. lifted their price target on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, Clorox has a consensus rating of “Hold” and a consensus target price of $158.21.
Clorox Stock Performance
CLX stock opened at $147.55 on Friday. The stock has a market capitalization of $18.26 billion, a PE ratio of 51.41, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. Clorox has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The company has a 50 day moving average price of $161.83 and a 200 day moving average price of $158.67.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same quarter in the prior year, the business posted $2.16 EPS.
Clorox Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.31%. Clorox’s dividend payout ratio (DPR) is presently 170.04%.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the company. Brooklyn Investment Group boosted its position in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after acquiring an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new stake in Clorox in the 3rd quarter worth about $27,000. Continuum Advisory LLC boosted its holdings in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after purchasing an additional 138 shares during the period. Asset Planning Inc acquired a new position in shares of Clorox during the 4th quarter worth approximately $32,000. Finally, Halbert Hargrove Global Advisors LLC bought a new position in shares of Clorox during the fourth quarter worth approximately $36,000. Institutional investors own 78.53% of the company’s stock.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- How to Calculate Stock Profit
- Uber’s Business, Cash Flow, and AI are Why it Will Set a New High
- How Can Investors Benefit From After-Hours Trading
- Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
- How to Most Effectively Use the MarketBeat Earnings Screener
- These are the 3 Stocks Most Likely to Split in 2025
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.